Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function

NCT00779922 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Impaired Renal Function

Interventions

DRUG: lenalidomide

Sponsor

Poitiers University Hospital